Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase.

MLA

Petzer, Anél, et al. “Azure B, a Metabolite of Methylene Blue, Is a High-Potency, Reversible Inhibitor of Monoamine Oxidase.” Toxicology and Applied Pharmacology, vol. 258, no. 3, Feb. 2012, pp. 403–09. EBSCOhost, https://doi.org/10.1016/j.taap.2011.12.005.

APA

Petzer, A., Harvey, B. H., Wegener, G., & Petzer, J. P. (2012). Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase. Toxicology and Applied Pharmacology, 258(3), 403–409. https://doi.org/10.1016/j.taap.2011.12.005

Chicago

Petzer, Anél, Brian H Harvey, Gregers Wegener, and Jacobus P Petzer. 2012. “Azure B, a Metabolite of Methylene Blue, Is a High-Potency, Reversible Inhibitor of Monoamine Oxidase.” Toxicology and Applied Pharmacology 258 (3): 403–9. doi:10.1016/j.taap.2011.12.005.